Regenxbio Inc (RGNX)

Cost of Revenue

$79.87M

TTM · Period ending: · USD

RGNX logo

RGNX Cost of Revenue

Latest reported$79.87M
RGNX TTM Cost of Revenue ($2.79M → $79.87M)
High-resolution chart · PNG

RGNX cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Regenxbio Inc Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
79,870,000
87,942,000
80,304,000
80,694,000
31,255,000
36,771,000
41,798,000
51,053,000
51,054,000
45,899,000
41,548,000
38,758,000
39,464,000
42,940,000
54,545,000
64,820,000
65,831,000
62,699,000
51,833,000
39,032,000
42,291,000
37,156,000
35,714,000
29,248,000
14,378,000
11,621,000
8,241,000
7,293,000
5,316,000
7,261,000
9,640,000
20,585,000
20,751,000
18,196,000
15,879,000
2,421,000
1,773,000
954,000
959,000
1,512,000
1,734,000
1,546,000
1,503,000
771,000
526,000
1,364,000
2,793,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.